 
    China Galaxy Investment Management is a legal person-owned investment institution.
China Galaxy Investment Management is a legal person-owned investment institution.The company's business strategy is: to build a national industrial guidance fund management platform and domestic private equity investment fund leading enterprises, to become a powerful investment and financing platform to promote the financial industry to serve the real economy and implement the national development strategy.
| 
                        Date
                        Company Name
                     | Round | Money Raised | Industry | Lead Investor | 
|---|---|---|---|---|
| 
                      Dec 17, 2018
                      
                            Eoroom Technology | Series A | ¥1.20B | Building Material | — | 
| 
                      Dec 11, 2018
                      
                            Cryofocus Biotech | Series A | $2.90M | Health Care | — | 
| 
                      May 18, 2018
                      
                           | Series A | — | Health Care | — | 
| 
                      Sep 25, 2017
                      
                            KeyPower | Angel | ¥3M | Automotive | — | 
| 
                      Jun 14, 2016
                      
                            AIJIYIN.COM.CN | Series A | ¥20M | Health Care | Yes | 
China Galaxy Investment Management has had 2 exits. China Galaxy Investment Management most notable exits include Cryofocus Biotech , KOTEI
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 30, 2022 | Cryofocus Biotech | IPO | Health Care | Detail | 
| Dec 22, 2021 | KOTEI | M&A | Automotive | Detail |